Tyra Biosciences (TYRA) Accumulated Depreciation (2020 - 2025)
Tyra Biosciences (TYRA) posted Accumulated Depreciation of $1.4 million for Q1 2025, up 8.74% on a QoQ basis from $1.3 million in Q4 2024, and up 50.43% year-over-year from $926000.0 in Q1 2024.
Tyra Biosciences (TYRA) Accumulated Depreciation (2020 - 2025) Analysis & Trends
Tyra Biosciences' Accumulated Depreciation history runs 6 years deep, the most recent figure standing at $1.4 million for Q1 2025.
- Quarterly Accumulated Depreciation rose 50.43% year-over-year to $1.4 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $1.4 million (up 50.43% YoY) and the FY2024 annual result came in at $1.3 million, up 58.74% from the prior year.
- Accumulated Depreciation was $1.4 million for Q1 2025 at Tyra Biosciences, up from $1.3 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $1.4 million in Q1 2025 and bottomed at $119000.0 in Q3 2021.
- A 5-year average of $678466.7 and a median of $629000.0 in 2023 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2021 — Accumulated Depreciation soared 293.02% — and 2025, when it jumped 50.43%.
- Tyra Biosciences' Accumulated Depreciation stood at $169000.0 in 2021, then jumped by 172.78% to $461000.0 in 2022, then soared by 75.05% to $807000.0 in 2023, then surged by 58.74% to $1.3 million in 2024, then gained by 8.74% to $1.4 million in 2025.
- Business Quant data shows TYRA's Accumulated Depreciation at $1.4 million in Q1 2025, $1.3 million in Q4 2024, and $1.2 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 926,000.00 |
| Dec 31, 2023 | 807,000.00 |
| Sep 30, 2023 | 706,000.00 |
| Jun 30, 2023 | 629,000.00 |
| Mar 31, 2023 | 544,000.00 |
| Dec 31, 2022 | 461,000.00 |
| Sep 30, 2022 | 379,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Mar 31, 2022 | 233,000.00 |
| Dec 31, 2021 | 169,000.00 |
| Sep 30, 2021 | 119,000.00 |
| Dec 31, 2020 | 43,000.00 |